3/26
08:12 am
adma
ADMA Biologics, Inc. (NASDAQ: ADMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.50 price target on the stock, up previously from $6.00.
Low
Report
ADMA Biologics, Inc. (NASDAQ: ADMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.50 price target on the stock, up previously from $6.00.
2/29
01:49 pm
adma
Rating for ADMA
Low
Report
Rating for ADMA
2/29
09:10 am
adma
ADMA Biologics, Inc. (NASDAQ: ADMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
ADMA Biologics, Inc. (NASDAQ: ADMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
1/22
09:13 am
adma
Rating for ADMA
Medium
Report
Rating for ADMA
1/22
09:13 am
adma
Rating for ADMA
Medium
Report
Rating for ADMA